Silvant Capital Management LLC Gilead Sciences, Inc. Transaction History

Silvant Capital Management LLC

$2.23 Billion
Q3 2024

A detailed history of Silvant Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Silvant Capital Management LLC holds 1,411 shares of GILD stock, worth $130,390. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,411

Previous 1,411 -0.0%

Holding current value

$130,390

Previous $96,000 22.92%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$57.92 - $72.58 $1.42 Million - $1.78 Million	-24,463 Reduced 94.55%	1,411 $84,000
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $94,724 - $107,514	-1,460 Reduced 5.34%	25,874 $1.88 Million
Q3 2021 Nov 08, 2021	SELL	$67.69 - $73.03 $167,329 - $180,530	-2,472 Reduced 8.29%	27,334 $1.91 Million
Q2 2021 Aug 03, 2021	SELL	$63.47 - $69.35 $42,651 - $46,603	-672 Reduced 2.2%	29,806 $2.05 Million
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $8,384 - $9,553	-148 Reduced 0.48%	30,478 $1.78 Million
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $33,285 - $41,850	-536 Reduced 1.72%	30,626 $1.94 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $10,352 - $11,387	-168 Reduced 0.54%	31,162 $2.03 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $18,065 - $19,941	-289 Reduced 0.91%	31,330 $1.99 Million
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $15,962 - $17,900	-258 Reduced 0.81%	31,619 $2.14 Million
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $11,255 - $12,609	-180 Reduced 0.56%	31,877 $2.07 Million
Q4 2018 Feb 06, 2019	SELL	$60.54 - $79.0 $2.21 Million - $2.88 Million	-36,438 Reduced 53.2%	32,057 $2.01 Million
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $33,216 - $36,776	-466 Reduced 0.68%	68,495 $5.29 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $55,861 - $65,160	861 Added 1.26%	68,961 $4.89 Million
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $4.96 Million - $6.05 Million	68,100 New	68,100 $5.13 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvant Capital Management LLC with notifications on news.

Account

Silvant Capital Management LLC Gilead Sciences, Inc. Transaction History